Document is current
Any future updates will be listed below
-
Authors
Vohhodina, Jekaterina https://orcid.org/0000-0001-8025-5190
Goehring, Liana J.
Liu, Ben
Kong, Qing
Botchkarev, Vladimir V.
Huynh, Mai
Liu, Zhiqi
Abderazzaq, Fieda O.
Clark, Allison P.
Ficarro, Scott B.
Marto, Jarrod A. https://orcid.org/0000-0003-2086-1134
Hatchi, Elodie https://orcid.org/0000-0001-8494-9851
Livingston, David M. https://orcid.org/0000-0001-5765-6025
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01CA080111, R01CA136512, 5R35CA242143-02)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Breast Cancer Research Foundation (BCRF-19-101)
Susan G. Komen (SAC140022)
the Gray Foundation, the BRCA Foundation, Evan M. and Cynthia Goldberg, and the Murray Winston Foundation.
- License Information
-
More Information
Article History
Received: 14 July 2020
Accepted: 11 May 2021
First Online: 10 June 2021
Competing interests
: D.M.L. is a Science Partner of and a Consultant to Nextech Invest (Zurich Switzerland); a consultant to Constellation Pharma, Boston, MA; a consultant to the Novartis Institute of Biomedical Research; a Scientific Committee Member of the Pezcoller Foundation (Trento, IT), and chairman of the Scientific Advisory Board (SAB) of the MIT Cancer Center, and a member of the SAB of The Sidney Kimmel-Johns Hopkins Cancer Center, and a Scientific Advisor to Cancer Research, UK. The remaining authors declare no competing interests.
